Detalhe da pesquisa
1.
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 399(10328): 945-955, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219377
2.
Evaluation of the reproducibility of responses to nasal allergen challenge and effects of inhaled nasal corticosteroids.
Clin Exp Allergy
; 53(11): 1187-1197, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794659
3.
Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma.
Allergy
; 76(9): 2797-2808, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33784411
4.
MP-AzeFlu in Moderate-to-Severe Allergic Rhinitis: A Literature Review.
Int Arch Allergy Immunol
; 182(11): 1026-1035, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082425
5.
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
N Engl J Med
; 376(12): 1131-1140, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28328347
6.
Comparison of upper and lower airway expression of SARS-COV-2 receptors in allergic asthma.
Allergy
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38726474
7.
Population pharmacokinetics of subcutaneous C1-inhibitor for prevention of attacks in patients with hereditary angioedema.
Clin Exp Allergy
; 48(10): 1325-1332, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29998524
8.
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.
Lancet Haematol
; 11(6): e436-e447, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710185
9.
A multicenter chart review of patient characteristics, treatment, and outcomes in hereditary angioedema: unmet need for more effective long-term prophylaxis.
Allergy Asthma Clin Immunol
; 19(1): 48, 2023 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37248521
10.
Canadian multidisciplinary expert consensus on the use of biologics in upper airways: a Delphi study.
J Otolaryngol Head Neck Surg
; 52(1): 30, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37095527
11.
Assessment of specific immunotherapy efficacy using a novel placebo score-based method.
Ann Allergy Asthma Immunol
; 109(5): 342-347.e1, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23062390
12.
Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled study.
Prim Care Respir J
; 21(3): 267-75, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22614920
13.
The burden of allergic rhinitis (AR) in Canada: perspectives of physicians and patients.
Allergy Asthma Clin Immunol
; 8(1): 7, 2012 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22656186
14.
Transitioning subcutaneous immunoglobulin 20% therapies in patients with primary and secondary immunodeficiencies: Canadian real-world study.
Allergy Asthma Clin Immunol
; 18(1): 70, 2022 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35934726
15.
Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen.
Allergy Asthma Proc
; 32(3): 239-47, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21535913
16.
Canadian clinical practice guidelines for acute and chronic rhinosinusitis.
Allergy Asthma Clin Immunol
; 7(1): 2, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21310056
17.
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Orphanet J Rare Dis
; 16(1): 86, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588897
18.
2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema.
Allergy Asthma Clin Immunol
; 6(1): 24, 2010 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20667127
19.
Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review.
Allergy Asthma Clin Immunol
; 16: 41, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32514272
20.
Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks.
J Allergy Clin Immunol Pract
; 7(6): 1793-1802.e2, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30772477